Skip to main content
Erschienen in: Endocrine 2/2015

01.06.2015 | Original Article

Time course of IL-15 expression after acute resistance exercise in trained rats: effect of diabetes and skeletal muscle phenotype

verfasst von: Mahdieh Molanouri Shamsi, Zuhair Mohammad Hassan, LeBris S. Quinn, Reza Gharakhanlou, Leila Baghersad, Mehdi Mahdavi

Erschienen in: Endocrine | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Type 1 diabetes is associated with skeletal muscle atrophy. Skeletal muscle is an endocrine organ producing myokines such as interleukin-15 (IL-15) and interleukin-6 (IL-6) in response to contraction. These factors may mediate the effects of exercise on skeletal muscle metabolism and anabolic pathways. Lack of correlation between muscle IL-15 mRNA and protein levels after exercise training has been observed, while regulatory effects of IL-6 on IL-15 expression have also been suggested. This study determined post-exercise changes in muscle IL-15 and IL-6 mRNA expression and IL-15 protein levels in healthy and streptozotocin-induced diabetic rats in both the fast flexor hallucis longus (FHL) and slow soleus muscles. Resistance training preserved FHL muscle weight in diabetic rats and increased IL-15 protein levels in both the soleus and FHL muscles. However, the temporal pattern of this response was distinct in normal and diabetic rats. Moreover, discordance between post-exercise muscle IL-15 mRNA and protein expression was observed in our study, and diabetes suppressed post-exercise increases in FHL muscle IL-6 mRNA expression. Our study indicates that training, skeletal muscle phenotype, and metabolic status all influence the temporal pattern of post-exercise changes in IL-15 expression. Muscle IL-15 protein levels increase following training, suggesting this may be an adaptation contributing to increased capacity for secretion of this myokine that is not depressed by the diabetic state.
Literatur
1.
Zurück zum Zitat B.C. Frier, E.G. Noble, M. Locke, Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-kappaB activation and expression. Cell Stress Chaperones 13(3), 287–296 (2008)CrossRefPubMedCentralPubMed B.C. Frier, E.G. Noble, M. Locke, Diabetes-induced atrophy is associated with a muscle-specific alteration in NF-kappaB activation and expression. Cell Stress Chaperones 13(3), 287–296 (2008)CrossRefPubMedCentralPubMed
2.
Zurück zum Zitat H. Andersen, P.C. Gadeberg, B. Brock, J. Jakobsen, Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 40(9), 1062–1069 (1997)CrossRefPubMed H. Andersen, P.C. Gadeberg, B. Brock, J. Jakobsen, Muscular atrophy in diabetic neuropathy: a stereological magnetic resonance imaging study. Diabetologia 40(9), 1062–1069 (1997)CrossRefPubMed
3.
Zurück zum Zitat T.J. Hawke, D.J. Garry, Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534–551 (2001)PubMed T.J. Hawke, D.J. Garry, Myogenic satellite cells: physiology to molecular biology. J. Appl. Physiol. 91, 534–551 (2001)PubMed
4.
Zurück zum Zitat P. Muñoz-Cánoves, C. Scheele, B.K. Pedersen, A.L. Serrano, Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 280(17), 4131–4148 (2013)CrossRefPubMedCentralPubMed P. Muñoz-Cánoves, C. Scheele, B.K. Pedersen, A.L. Serrano, Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 280(17), 4131–4148 (2013)CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat T. Henriksen, C. Green, B.K. Pedersen, Myokines in myogenesis and health. Recent Pat. Biotechnol. 6(3), 167–171 (2012)CrossRefPubMed T. Henriksen, C. Green, B.K. Pedersen, Myokines in myogenesis and health. Recent Pat. Biotechnol. 6(3), 167–171 (2012)CrossRefPubMed
6.
Zurück zum Zitat L.S. Quinn, L. Strait-Bodey, B.G. Anderson, J.M. Argile´s, P.J. Havel, Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol. Int. 29, 449–457 (2005)CrossRefPubMed L.S. Quinn, L. Strait-Bodey, B.G. Anderson, J.M. Argile´s, P.J. Havel, Interleukin-15 stimulates adiponectin secretion by 3T3-L1 adipocytes: evidence for a skeletal muscle-to-fat signaling pathway. Cell Biol. Int. 29, 449–457 (2005)CrossRefPubMed
7.
Zurück zum Zitat T.A. Fehniger, M.A. Caligiuri, Interleukin-15: biology and relevance to human disease. Blood 97(4), 14–32 (2001)CrossRefPubMed T.A. Fehniger, M.A. Caligiuri, Interleukin-15: biology and relevance to human disease. Blood 97(4), 14–32 (2001)CrossRefPubMed
8.
Zurück zum Zitat N.G. Barra, M.V. Chew, S. Reid, A.A. Ashkar, Interleukin-15 treatment induces weight loss independent of lymphocytes. PLoS ONE 7(6), e39553 (2012)CrossRefPubMedCentralPubMed N.G. Barra, M.V. Chew, S. Reid, A.A. Ashkar, Interleukin-15 treatment induces weight loss independent of lymphocytes. PLoS ONE 7(6), e39553 (2012)CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat L.S. Quinn, B.G. Anderson, J.D. Conner, E.E. Pistilli, T. Wolden-Hanson, Overexpression of interleukin-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle metabolism. Int J Interferon, Cytokine Mediat Res 3, 29–42 (2011)CrossRef L.S. Quinn, B.G. Anderson, J.D. Conner, E.E. Pistilli, T. Wolden-Hanson, Overexpression of interleukin-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle metabolism. Int J Interferon, Cytokine Mediat Res 3, 29–42 (2011)CrossRef
10.
Zurück zum Zitat N.G. Barra, M.V. Chew, A.C. Holloway, A.A. Ashkar, Interleukin-15 treatment improves glucose homeostasis and insulin sensitivity in obese mice. Diabetes Obes. Metab. 14, 190–193 (2012)CrossRefPubMed N.G. Barra, M.V. Chew, A.C. Holloway, A.A. Ashkar, Interleukin-15 treatment improves glucose homeostasis and insulin sensitivity in obese mice. Diabetes Obes. Metab. 14, 190–193 (2012)CrossRefPubMed
11.
Zurück zum Zitat S. Busquets, M. Figueras, V. Almendro, F.J. Lopez-Soriano, J.M. Arg-iles, Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine. Biochim. Biophys. Acta 1760, 1613–1617 (2006)CrossRefPubMed S. Busquets, M. Figueras, V. Almendro, F.J. Lopez-Soriano, J.M. Arg-iles, Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine. Biochim. Biophys. Acta 1760, 1613–1617 (2006)CrossRefPubMed
12.
Zurück zum Zitat M.M. Shamsi, Z.H. Hassan, R. Gharakhanlou, L.S. Quinn, K. Azadmanesh, L. Baghersad et al., Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training. Endocrine 46(1), 60–69 (2014)CrossRef M.M. Shamsi, Z.H. Hassan, R. Gharakhanlou, L.S. Quinn, K. Azadmanesh, L. Baghersad et al., Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training. Endocrine 46(1), 60–69 (2014)CrossRef
13.
Zurück zum Zitat H.J. Kim, J.Y. Park, S.L. Oh, Y.A. Kim, B. So, J.K. Seong, W. Song, Effect of treadmill exercise on interleukin-15 expression and glucose tolerance in zucker diabetic fatty rats. Diabetes Metab J 37(5), 358–364 (2013)CrossRefPubMedCentralPubMed H.J. Kim, J.Y. Park, S.L. Oh, Y.A. Kim, B. So, J.K. Seong, W. Song, Effect of treadmill exercise on interleukin-15 expression and glucose tolerance in zucker diabetic fatty rats. Diabetes Metab J 37(5), 358–364 (2013)CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat B.K. Pedersen, C.P. Fischer, Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care 10, 265–271 (2007)CrossRefPubMed B.K. Pedersen, C.P. Fischer, Physiological roles of muscle-derived interleukin-6 in response to exercise. Curr Opin Clin Nutr Metab Care 10, 265–271 (2007)CrossRefPubMed
15.
Zurück zum Zitat C. Keller, A. Steensberg, H. Pilegaard, T. Osada, B. Saltin, B.K. Pedersen et al., Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 15(14), 2748–2750 (2001)PubMed C. Keller, A. Steensberg, H. Pilegaard, T. Osada, B. Saltin, B.K. Pedersen et al., Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J 15(14), 2748–2750 (2001)PubMed
16.
Zurück zum Zitat M.A. Febbraio, B.K. Pedersen, Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16, 1335–1347 (2002)CrossRefPubMed M.A. Febbraio, B.K. Pedersen, Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16, 1335–1347 (2002)CrossRefPubMed
17.
Zurück zum Zitat Q.S. Tao, H.L. Huang, Y. Chai, X. Luo, X.L. Zhang, B. Jia et al., Interleukin-6 up-regulates the expression of interleukin-15 is associated with MAPKsand PI3-K signaling pathways in the human keratinocyte cell line, HaCaT. Mol Biol Rep 39(4), 4201–4205 (2012)CrossRefPubMed Q.S. Tao, H.L. Huang, Y. Chai, X. Luo, X.L. Zhang, B. Jia et al., Interleukin-6 up-regulates the expression of interleukin-15 is associated with MAPKsand PI3-K signaling pathways in the human keratinocyte cell line, HaCaT. Mol Biol Rep 39(4), 4201–4205 (2012)CrossRefPubMed
18.
Zurück zum Zitat S.Q. Zhang, X. Luo, S. Yang, J.L. Liu, C.J. Yang, X.Y. Yin et al., Auto inhibition of IL-15 expression in KC cells is ERK1/2 and PI3K dependent. Basic Immun 68, 397–404 (2008) S.Q. Zhang, X. Luo, S. Yang, J.L. Liu, C.J. Yang, X.Y. Yin et al., Auto inhibition of IL-15 expression in KC cells is ERK1/2 and PI3K dependent. Basic Immun 68, 397–404 (2008)
19.
Zurück zum Zitat P.A. Farrell, M.J. Fedele, J. Hernandez, J.D. Fluckey, J.L. Miller 3rd, C.H. Lang et al., Hypertrophy of skeletal muscle in diabetic rats in response to chronic resistance exercise. J. Appl. Physiol. 87(3), 1075–1082 (1999)PubMed P.A. Farrell, M.J. Fedele, J. Hernandez, J.D. Fluckey, J.L. Miller 3rd, C.H. Lang et al., Hypertrophy of skeletal muscle in diabetic rats in response to chronic resistance exercise. J. Appl. Physiol. 87(3), 1075–1082 (1999)PubMed
20.
Zurück zum Zitat E. Talebi-Garakani, A. Safarzade, Resistance training decreases serum inflammatory markers in diabetic rats. Endocrine 43(3), 564–570 (2013)CrossRefPubMed E. Talebi-Garakani, A. Safarzade, Resistance training decreases serum inflammatory markers in diabetic rats. Endocrine 43(3), 564–570 (2013)CrossRefPubMed
21.
Zurück zum Zitat A.R. Nielsen, R. Mounier, P. Plomgaard, O.H. Mortensen, M. Penkowa, T. Speerschneider et al., Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol 584, 305–312 (2007)CrossRefPubMedCentralPubMed A.R. Nielsen, R. Mounier, P. Plomgaard, O.H. Mortensen, M. Penkowa, T. Speerschneider et al., Expression of interleukin-15 in human skeletal muscle effect of exercise and muscle fibre type composition. J Physiol 584, 305–312 (2007)CrossRefPubMedCentralPubMed
22.
Zurück zum Zitat N.E. Zanchi, F.S. Lira, M.A. de Siqueira Filho, J.C. Rosa, C.R. de Oliveira Carvalho, M. Seelaender et al., Chronic low frequency/low volume resistance training reduces pro-inflammatory cytokine protein levels and TLR4 mRNA in rat skeletal muscle. Eur J Appl Physiol 109(6), 1095–1102 (2010)CrossRefPubMed N.E. Zanchi, F.S. Lira, M.A. de Siqueira Filho, J.C. Rosa, C.R. de Oliveira Carvalho, M. Seelaender et al., Chronic low frequency/low volume resistance training reduces pro-inflammatory cytokine protein levels and TLR4 mRNA in rat skeletal muscle. Eur J Appl Physiol 109(6), 1095–1102 (2010)CrossRefPubMed
23.
Zurück zum Zitat S. Lee, E.R. Barton, H.L. Sweeney, R.P. Farrar, Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J. Appl. Physiol. 96(3), 1097–1104 (2004)CrossRefPubMed S. Lee, E.R. Barton, H.L. Sweeney, R.P. Farrar, Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J. Appl. Physiol. 96(3), 1097–1104 (2004)CrossRefPubMed
24.
Zurück zum Zitat K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402–408 (2001)CrossRefPubMed K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402–408 (2001)CrossRefPubMed
25.
Zurück zum Zitat M.M. Bradford, A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976)CrossRefPubMed M.M. Bradford, A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254 (1976)CrossRefPubMed
26.
Zurück zum Zitat L.S. Quinn, B.G. Anderson, L. Strait-Bodey, T. Wolden-Hanson, Serum and muscle interleukin-15 levels decrease in aging mice: correlation with declines in soluble interleukin-15 receptor alpha expression. Exp. Gerontol. 45(2), 106–112 (2010)CrossRefPubMedCentralPubMed L.S. Quinn, B.G. Anderson, L. Strait-Bodey, T. Wolden-Hanson, Serum and muscle interleukin-15 levels decrease in aging mice: correlation with declines in soluble interleukin-15 receptor alpha expression. Exp. Gerontol. 45(2), 106–112 (2010)CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat E. Marzetti, C.S. Carter, S.E. Wohlgemuth, H.A. Lees, S. Giovannini, B. Anderson et al., Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech. Ageing Dev. 130(4), 272–280 (2009)CrossRefPubMedCentralPubMed E. Marzetti, C.S. Carter, S.E. Wohlgemuth, H.A. Lees, S. Giovannini, B. Anderson et al., Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction. Mech. Ageing Dev. 130(4), 272–280 (2009)CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat G. Begue, A. Douillard, O. Galbes, B. Rossano, B. Vernus, R. Candau et al., Early activation of rat skeletal muscle IL-6/STAT1/STAT3 dependent gene expression in resistance exercise linked to hypertrophy. PLoS ONE 8(2), e57141 (2013)CrossRefPubMedCentralPubMed G. Begue, A. Douillard, O. Galbes, B. Rossano, B. Vernus, R. Candau et al., Early activation of rat skeletal muscle IL-6/STAT1/STAT3 dependent gene expression in resistance exercise linked to hypertrophy. PLoS ONE 8(2), e57141 (2013)CrossRefPubMedCentralPubMed
29.
Zurück zum Zitat E.E. Spangenburg, D.A. Brown, Johnson, R.L. Moore, Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J Physiol 572, 839–848 (2006)CrossRefPubMedCentralPubMed E.E. Spangenburg, D.A. Brown, Johnson, R.L. Moore, Exercise increases SOCS-3 expression in rat skeletal muscle: potential relationship to IL-6 expression. J Physiol 572, 839–848 (2006)CrossRefPubMedCentralPubMed
30.
Zurück zum Zitat M. Izquierdo, J. Ibañez, J.A.L. Calbet, I. Navarro-Amezqueta, M. González-Izal, F. Idoate et al., Cytokine and hormone responses to resistance training. Eur. J. Appl. Physiol. 107, 397–409 (2009)CrossRefPubMed M. Izquierdo, J. Ibañez, J.A.L. Calbet, I. Navarro-Amezqueta, M. González-Izal, F. Idoate et al., Cytokine and hormone responses to resistance training. Eur. J. Appl. Physiol. 107, 397–409 (2009)CrossRefPubMed
31.
Zurück zum Zitat M. Flueck, Tuning of mitochondrial pathways by muscle work: from triggers to sensors and expression signatures. Appl. Physiol. Nutr. Metab. 34, 447–453 (2009)CrossRefPubMed M. Flueck, Tuning of mitochondrial pathways by muscle work: from triggers to sensors and expression signatures. Appl. Physiol. Nutr. Metab. 34, 447–453 (2009)CrossRefPubMed
32.
Zurück zum Zitat H. Pilegaard, G.A. Ordway, B. Saltin, P.D. Neufer, Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279, E806–E814 (2000)PubMed H. Pilegaard, G.A. Ordway, B. Saltin, P.D. Neufer, Transcriptional regulation of gene expression in human skeletal muscle during recovery from exercise. Am J Physiol Endocrinol Metab 279, E806–E814 (2000)PubMed
33.
Zurück zum Zitat L.S. Quinn, B.G. Anderson, J.D. Conner, T. Wolden-Hanson, T.J. Marcell, IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice. Endocrinology 155(1), 143–155 (2014)CrossRefPubMed L.S. Quinn, B.G. Anderson, J.D. Conner, T. Wolden-Hanson, T.J. Marcell, IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice. Endocrinology 155(1), 143–155 (2014)CrossRefPubMed
34.
Zurück zum Zitat S.E. Riechman, G. Balasekaran, S.M. Roth, R.E. Ferrell, Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol 97(6), 2214–2219 (2004)CrossRefPubMed S.E. Riechman, G. Balasekaran, S.M. Roth, R.E. Ferrell, Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol 97(6), 2214–2219 (2004)CrossRefPubMed
35.
Zurück zum Zitat R.S. Staron, R.S. Hikida, T.F. Murray, M.M. Nelson, P. Johnson, F.C. Hagerman, Assessment of skeletal muscle damage in successive biopsies from strength-trained and untrained men and women. Eur. J. Appl. Physiol. 65, 258–264 (1992)CrossRef R.S. Staron, R.S. Hikida, T.F. Murray, M.M. Nelson, P. Johnson, F.C. Hagerman, Assessment of skeletal muscle damage in successive biopsies from strength-trained and untrained men and women. Eur. J. Appl. Physiol. 65, 258–264 (1992)CrossRef
36.
Zurück zum Zitat S.M. Roth, G.F. Martel, F.M. Ivey, J.T. Lemmer, E.J. Metter, B.F. Hurley, M.A. Rogers, High-volume, heavy-resistance strength training and muscle damage in young and older women. J. Appl. Physiol. 88(3), 1112–1118 (2000)PubMed S.M. Roth, G.F. Martel, F.M. Ivey, J.T. Lemmer, E.J. Metter, B.F. Hurley, M.A. Rogers, High-volume, heavy-resistance strength training and muscle damage in young and older women. J. Appl. Physiol. 88(3), 1112–1118 (2000)PubMed
37.
Zurück zum Zitat L.S. Quinn, B.G. Anderson, R.H. Drivdahl, B. Alvarez, J.M. Argilés, Overexpression of interleukin15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res 280(1), 55–63 (2002)CrossRefPubMed L.S. Quinn, B.G. Anderson, R.H. Drivdahl, B. Alvarez, J.M. Argilés, Overexpression of interleukin15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res 280(1), 55–63 (2002)CrossRefPubMed
Metadaten
Titel
Time course of IL-15 expression after acute resistance exercise in trained rats: effect of diabetes and skeletal muscle phenotype
verfasst von
Mahdieh Molanouri Shamsi
Zuhair Mohammad Hassan
LeBris S. Quinn
Reza Gharakhanlou
Leila Baghersad
Mehdi Mahdavi
Publikationsdatum
01.06.2015
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2015
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0501-x

Weitere Artikel der Ausgabe 2/2015

Endocrine 2/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.